Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study

Santos, Marcelo A. M.; Souto, Francisco J. D.
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p32
Academic Journal
Background: Hepatitis C virus (HCV) is a significant problem for patients undergoing hemodialysis therapy. This situation has never been studied in Mato Grosso state, central Brazil. This study was conducted aiming to estimate the prevalence of the anti-HCV and the incidence of seroconversion in the main metropolitan region of the state. Methods: 433 patients from the six hemodialysis units were interviewed and anti-HCV was tested by a third-generation enzyme immunoassay. An open cohort of patients who tested negative for anti-HCV at the entry of the study was created and seroconversions was assessed monthly. The staff responsible for the units were interviewed to assess whether the infection control measures were being followed. Logistic and Cox regression analysis were performed in order to assess risk factor to HCV. Results: The entry on the study took place between January 2002 and June 2005. 73 out of 433 (16.9%, CI95%: 13.3-20.8) was found to be anti-HCV reactive. The multivariate analysis indicated as risk factors associated to anti-HCV the duration of the hemodialysis treatment, the number of transfusions received, and the unit of treatment. An open cohort of 360 patients who tested negative for anti-HCV was created, with a following average of 24 (± 15) months. Forty seroconversions were recorded corresponding to an incidence density of 4.6/1000 patient-months, ranges 0 to 30 among the units. Cox regression indicated the time of hemodialysis (RR = 2.2; CI95%: 1.1-4.6; p < 0.05) and the unit where treatment was performed (RR = 42.4; CI95%: 9.9-180.5; p < 0.05) as risk factors for seroconversion. The three units with highest anti-HCV prevalence and incidence were identified as those that more frequently failed to apply control measures. Conclusion: The study demonstrated high prevalence and incidence of anti-HCV in some of the hemodialysis units. Time on hemodialysis therapy was an independent factor associated to HCV. Blood transfusion was associated with anti-HCV in initial survey but was not important in incident cases. Failure of applying control meaures was more evident in units with the highest HCV prevalence and incidence. The results suggest that nosocomial transmission was the main spread factor of HCV in the studied population.


Related Articles

  • HCV in Patients With End-Stage Renal Disease. Okoh, Emuejevoke J.; Bucci, Jay R.; Simon, James F.; Harrison, Stephen A. // American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p2123 

    Chronic hepatitis C virus (HCV) infection remains an important cause of liver disease in patients with end-stage renal disease (ESRD) and conversely, renal failure has a significant impact on morbidity and mortality throughout the natural history of chronic HCV and its treatment. With improved...

  • Literature Abstracts.  // Pediatric Nephrology;Sep2001, Vol. 16 Issue 9, p732 

    Presents abstracts of articles concerning kidney diseases, featured in the 2001 issue of the periodical 'Pediatric Nephrology.' Dynamics of prehemodialysis and posthemodialysis blood hepatitis C virus levels; Role of high concentration of calcium in the urine in osmole-free water diuresis.

  • Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Reddy, A. K.; Dakshinamurty, K. V.; Lakshmi, V. // Indian Journal of Medical Microbiology;Jan2006, Vol. 24 Issue 1, p55 

    An enzyme immuno assay for hepatitis C core antigen was recently developed and its performance was compared with that of the hepatitis C virus (HCV) RNA in the screening of HCV infection in patients on hemodialysis. One hundred and eleven chronic renal failure patients undergoing haemodialysis...

  • Sustained Virological Response to Interferon Plus Ribavirin Reduces Non–Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus. Berenguer, Juan; Rodríguez, Elena; Miralles, Pilar; Von Wichmann, Miguel A.; López-Aldeguer, José; Mallolas, Josep; Galindo, María J.; Van Den Eynde, Eva; Téllez, María J.; Quereda, Carmen; Jou, Antoni; Sanz, José; Barros, Carlos; Santos, Ignacio; Pulido, Federico; Guardiola, Josep M.; Ortega, Enrique; Rubio, Rafael; Jusdado, Juan J.; Montes, María L. // Clinical Infectious Diseases;Sep2012, Vol. 55 Issue 5, p728 

    We observed that eradication of hepatitis C virus in patients coinfected with human immunodeficiency virus (HIV) was associated not only with a reduction in liver-related complications and mortality but also with a reduction in the progression of HIV infection and mortality not related to liver...

  • Association between cold dialysis and cardiovascular survival in hemodialysis patients. Hsu, Heng-Jung; Yen, Chiung-Hui; Hsu, Kuang-Hung; Lee, Chin-Chan; Chang, Shu-Ju; Wu, I-Wen; Sun, Chiao-Yin; Chou, Chia-Chi; Yu, Chen-Chao; Hsieh, Ming-Fang; Chen, Chun-Yu; Hsu, Chiao-Ying; Weng, Cheng-Hao; Tsai, Chi-Jen; Wu, Mai-Szu // Nephrology Dialysis Transplantation;Jun2012, Vol. 27 Issue 6, p2457 

    Background. Higher cardiovascular mortality has been noted in patients with chronic kidney disease (CKD). CKD patients are also known to have impaired energy expenditure but the role of energy expenditure in cardiovascular disease is not yet known. Furthermore, the association between cold...

  • Uremic Pruritus, Dialysis Adequacy, and Metabolic Profiles in Hemodialysis Patients: A Prospective 5-Year Cohort Study. Ko, Mei-Ju; Wu, Hon-Yen; Chen, Hung-Yuan; Chiu, Yen-Ling; Hsu, Shih-Ping; Pai, Mei-Fen; Ju-YehYang; Lai, Chun-Fu; Lu, Hui-Min; Huang, Shu-Chen; Yang, Shao-Yu; Wen, Su-Yin; Chiu, Hsien-Ching; Hu, Fu-Chang; Peng, Yu-Sen; Jee, Shiou-Hwa // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: Uremic pruritus is a common and intractable symptom in patients on chronic hemodialysis, but factors associated with the severity of pruritus remain unclear. This study aimed to explore the associations of metabolic factors and dialysis adequacy with the aggravation of pruritus....

  • Re-infection following sustained virological response with a different hepatitis C virus genotype: implications for infection control policy. O'Shaughnessy, Michelle M.; O'Regan, John A.; Murray, Frank E.; Connell, Jeff A.; Duffy, Margaret P.; Francis, Veronica M.; Dwyer, Sharon; Thornton, Lelia M.; Conlon, Peter J. // Nephrology Dialysis Transplantation;Jun2012, Vol. 5 Issue 3, p250 

    We report the case of a 45-year-old haemodialysis patient who achieved a sustained virological response (SVR) following pegylated interferon therapy for hepatitis C virus (HCV) genotype 2 infection. He was subsequently cohorted with other HCV-infected dialysis patients and became re-infected...

  • Journal Club.  // Kidney International;Apr2012, Vol. 81 Issue 8, p718 

    The article discusses several studies on various diseases including Hepatitis C virus (HCV), blood disorder, and pseudohypoaldosteronism type II (PHAII). It says that researcher Lok and colleagues investigate the benefits of antiviral agents to HCV genotype 1 carriers. It states that a team led...

  • Incident Hepatitis C Virus Infection among US HIV-Infected Men Enrolled in Clinical Trials. Taylor, Lynn E.; Holubar, Marisa; Wu, Kunling; Bosch, Ronald J.; Wyles, David L.; Davis, John A.; Mayer, Kenneth H.; Sherman, Kenneth E.; Tashima, Karen T. // Clinical Infectious Diseases;Mar2011, Vol. 52 Issue 6, p812 

    HCV incidence from 1996-2008 among HIV-infected men in U.S. HIV therapeutic trials was 0.51 per 100 person-years. Incident HCV occurred primarily through non-parenteral means; 75% of seroconverters reported no drug injection. At-risk HIV-infected persons should have access to HCV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics